Overview
Background
David graduated from the University of London with a BSc (Hons) in biochemistry (King’s College) and PhD which investigated the role of epidermal growth factor receptors in liver regeneration (Imperial College). Since then he has worked on a variety of projects including; immunoassay development (Ortho Clinical Diagnostics); artificial liver machine development (Imperial College); and p53 mutations in liver cancer (QIMR). He joined the Department of Nephrology at the Princess Alexandra Hospital in Brisbane in 1999. He is a senior lecturer in The University of Queensland Faculty of Medicine, a senior member of the UQ Kidney Disease Research Laboratory and manages the Princess Alexandra Hospital Endotoxin Testing Service.
His main research interests are in the area of renal tubulointerstitial fibrosis, inflammation and also the mechanisms of renal cancer development – particularly the role that cytokines and growth factors play in these processes. Current projects include the role of protease activated receptor-2 in renal scarring, inflammation and cancer, the mechanism of heavy metal toxicity in the kidney and the renoprotective properties of erythropoietin. The Princess Alexandra Hospital Endotoxin Testing Service routinely tests samples from dialysis units throughout Queensland.
Availability
- Associate Professor David Vesey is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Biochemistry, King's College London
- Doctor of Philosophy of Gastroenterology and Hepatology, Imperial College London
Works
Search Professor David Vesey’s works on UQ eSpace
2001
Conference Publication
Interleukin-1B (IL-1B) stimulates human renal cortical fibroblast (CF) DNA synthesis and extracellular matrix production through a transforming growth factor-beta (TGFB) dependent mechanism
Vesey, D. A., Cheung, C., Gobe, G., Endre, Z. and Johnson, D. W. (2001). Interleukin-1B (IL-1B) stimulates human renal cortical fibroblast (CF) DNA synthesis and extracellular matrix production through a transforming growth factor-beta (TGFB) dependent mechanism. 37th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Darwin, NT, 5th - 7th September, 2001. Carlton, VIC: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-140.x
2001
Journal Article
Inhibition of proliferation of HT-29 colon adenocarcinorna cells by carboxylate NSAIDs and their acyl glucuronides
Cannell, G. R., Vesey, D. A. and Dickinson, R. G. (2001). Inhibition of proliferation of HT-29 colon adenocarcinorna cells by carboxylate NSAIDs and their acyl glucuronides. Life Sciences, 70 (1), 37-48. doi: 10.1016/S0024-3205(01)01370-4
2000
Journal Article
Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients
Johnson, David W., Kay, Troy D., Vesey, David A., Isbel, Nicole, Campbell, Scott B. and Hawley, Carmel M. (2000). Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients. Peritoneal Dialysis International, 20 (6), 766-771.
2000
Conference Publication
Interleukin-1b (IL-1b)
Vesey, D. A., Cheung, C., Endre, Z. H., Gobe, G. C. and Johnson, D. W. (2000). Interleukin-1b (IL-1b). ANZSN Annual Scientific Meeting, Melbourne, Vic, 15-17 Mar, 2000. Sydney: Australian & New Zealand Society of Nephrology.
2000
Journal Article
Preparation and characterization of polyclonal antibodies against human chaperonin 10
Somodevilla-Torres, Maria J., Hillyard, Narelle C., Morton, Halle, Alewood, Dianne, Halliday, Judy A., Alewood, Paul F., Vesey, David A., Walsh, Michael D. and Cavanagh, Alice C. (2000). Preparation and characterization of polyclonal antibodies against human chaperonin 10. Cell Stress and Chaperones, 5 (1), 14-20. doi: 10.1379/1466-1268(2000)0052.0.CO;2
2000
Conference Publication
Cyclosporin (CyA) promotes human renal cortical fibroblast (CF) toxicity, extracellular matrix deposition and nitric oxide (NO) release
Vesey, D. A., Cheung, C., Endre, Z. H., Gobe, G. C. and Johnson, D. W. (2000). Cyclosporin (CyA) promotes human renal cortical fibroblast (CF) toxicity, extracellular matrix deposition and nitric oxide (NO) release. ANZSN Annual Scientific Meeting, Melbourne, 15-17 Mar, 2000.
2000
Journal Article
Enalaprilat directly ameliorates in vitro cyclosporin nephrotoxicity in human tubulo-interstitial cells
Johnson, D. W., Saunders, H. J., Vesey, D. A., Qi, W., Field, M. J. and Pollock, C. A. (2000). Enalaprilat directly ameliorates in vitro cyclosporin nephrotoxicity in human tubulo-interstitial cells. Nephron, 86 (4), 473-481. doi: 10.1159/000045837
1994
Journal Article
P53 Gene in Hepatocellular Carcinomas From Australia
Vesey, DA, Hayward, NK and Cooksley, Wge (1994). P53 Gene in Hepatocellular Carcinomas From Australia. Cancer Detection and Prevention, 18 (2), 123-130.
1993
Journal Article
Down-Regulation of Epidermal Growth-Factor Receptors in Liver Proliferation Induced by a Mixture of Triiodothyronine, Amino-Acids, Glucagon, and Heparin (tagh)
Vesey, DA, Selden, AC and Hodgson, Hjf (1993). Down-Regulation of Epidermal Growth-Factor Receptors in Liver Proliferation Induced by a Mixture of Triiodothyronine, Amino-Acids, Glucagon, and Heparin (tagh). Gut, 34 (11), 1601-1606. doi: 10.1136/gut.34.11.1601
1993
Journal Article
Effect of Luminal Growth-Factor Preservation On Intestinal Growth
Playford, RJ, Woodman, AC, Clark, P, Watanapa, P, Vesey, D, Deprez, PH, Williamson, Rcn and Calam, J (1993). Effect of Luminal Growth-Factor Preservation On Intestinal Growth. Lancet, 341 (8849), 843-848. doi: 10.1016/0140-6736(93)93057-8
1992
Journal Article
Galactosamine Induced Hepatitis Induces a Reduction in Hepatocyte Epidermal Growth-Factor Receptors
Vesey, DA, Woodman, AC and Hodgson, Hjf (1992). Galactosamine Induced Hepatitis Induces a Reduction in Hepatocyte Epidermal Growth-Factor Receptors. Gut, 33 (7), 954-958. doi: 10.1136/gut.33.7.954
1992
Journal Article
Effect of Invivo Administration of An Antibody to Epidermal Growth-Factor On the Rapid Increase in Dna-Synthesis Induced by Partial-Hepatectomy in the Rat
Vesey, DA, Selden, AC, Woodman, AC and Hodgson, Hjf (1992). Effect of Invivo Administration of An Antibody to Epidermal Growth-Factor On the Rapid Increase in Dna-Synthesis Induced by Partial-Hepatectomy in the Rat. Gut, 33 (6), 831-835. doi: 10.1136/gut.33.6.831
1992
Journal Article
Comparative Effects of Epidermal Growth-Factor, An Insulin-Glucagon Combination, and a Hepatocyte Growth-Factor Preparation On Epidermal Growth-Factor Receptors
Vesey, DA, Selden, AC and Hodgson, Hjf (1992). Comparative Effects of Epidermal Growth-Factor, An Insulin-Glucagon Combination, and a Hepatocyte Growth-Factor Preparation On Epidermal Growth-Factor Receptors. Journal of Hepatology, 15 (1-2), 107-113. doi: 10.1016/0168-8278(92)90020-P
1991
Journal Article
Gastric Output of Pancreatic Secretory Trypsin-Inhibitor Is Increased by Misoprostol
Playford, RJ, Batten, JJ, Freeman, TC, Beardshall, K, Vesey, DA, Fenn, GC, Baron, JH and Calam, J (1991). Gastric Output of Pancreatic Secretory Trypsin-Inhibitor Is Increased by Misoprostol. Gut, 32 (11), 1396-1400. doi: 10.1136/gut.32.11.1396
1991
Journal Article
Dose-Dependent Effects of Fentanyl On Indomethacin-Induced Gastric Damage
Playford, RJ, Vesey, DA, Haldane, S, Alison, MR and Calam, J (1991). Dose-Dependent Effects of Fentanyl On Indomethacin-Induced Gastric Damage. Digestion, 49 (4), 198-203. doi: 10.1159/000200722
1991
Journal Article
Dimethyl-Sulfoxide Induces a Reduced Growth-Rate, Altered Cell Morphology and Increased Epidermal-Growth-Factor Binding in Hep G2 Cells
Vesey, DA, Cunningham, JM, Selden, AC, Woodman, AC and Hodgson, Hjf (1991). Dimethyl-Sulfoxide Induces a Reduced Growth-Rate, Altered Cell Morphology and Increased Epidermal-Growth-Factor Binding in Hep G2 Cells. Biochemical Journal, 277 (3), 773-777. doi: 10.1042/bj2770773
Funding
Past funding
Supervision
Availability
- Associate Professor David Vesey is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Exploring Magnetic Resonance for Differentiating between Progressive and Non-Progressive Chronic Kidney Disease
Associate Advisor
Other advisors: Associate Professor Ross Francis, Dr Robert Ellis
-
Doctor Philosophy
Exploring Magnetic Resonance for Differentiating between Progressive and Non-Progressive Chronic Kidney Disease
Associate Advisor
Other advisors: Dr Robert Ellis, Associate Professor Ross Francis
Completed supervision
-
2021
Doctor Philosophy
Clinical Biobanking and the Distinguishing Risk of Progressive Chronic Kidney Disease Study
Associate Advisor
-
2020
Doctor Philosophy
Exploring Resistance of Renal Cell Carcinoma to Sunitinib Therapy
Associate Advisor
Other advisors: Professor Hemamali Samaratunga
-
2020
Doctor Philosophy
The role of the adipose tissue microenvironment in kidney cancer
Associate Advisor
Other advisors: Professor David Johnson
-
2016
Doctor Philosophy
Bioactive compounds from Australian Blacklip Abalone (Haliotis rubra) processing waste
Associate Advisor
-
2009
Doctor Philosophy
Targeting genes for identification and treatment of renal cell carcinoma
Associate Advisor
Other advisors: Professor David Johnson
Media
Enquiries
For media enquiries about Associate Professor David Vesey's areas of expertise, story ideas and help finding experts, contact our Media team: